Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 34 (RPL32P34) is a processed pseudogene related to the ribosomal protein L32 gene family[6]. As a pseudogene, it is a non-functional genomic DNA sequence resembling the functional ribosomal protein L32 gene (RPL32) but lacks protein-coding capability[6]. It does not encode a functional protein and is not known to have any direct biological function or role as a therapeutic target[6]. There is no evidence in the current literature to suggest it is involved in disease processes or is a target for approved drugs. Pseudogenes such as RPL32P34 are distinct from their parental genes and generally do not contribute to protein synthesis or canonical cellular pathways[6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 34 (RPL32P34).